Actinic Keratosis Treatment Market Overview
Actinic keratosis is a skin condition caused by repeated excessive exposure to solar radiation. It results in an area of skin becoming scaly or crusty. The development of actinic keratosis is linked to exposure to ultraviolet radiation from the sun, which causes abnormal proliferation of mutated keratinocytes situated in the lower layers of the epidermis. As a result, actinic keratosis manifests as a pre-cancerous condition which can develop malignancies if left untreated. These lesions can appear on the face, neck, and arms, with middle-aged and elderly people who have been exposed to solar radiation continuously for long time appearing to be at the highest risk of disease. People working with tar and coal are more likely to get actinic keratosis. Actinic keratosis can develop into squamous cell carcinoma if left untreated. Increasing efforts to wipe out cancer by developing stronger treatments is projected to accelerate the market growth during the forecast period (2019-2027).
Market Size and Forecast
The actinic keratosis treatment market is anticipated to record a CAGR of around 5.65% over the forecast period. The market is segmented by type into medications and procedures; by end user into hospitals & oncology centers, dermatology clinics and ambulatory surgical center. Hospitals & oncology centers segment is projected to capture the largest market share owing to ease of accessibility and availability to patients and rise in healthcare infrastructure, especially in developing economies.
Get more information on this report: Download Sample PDF
Abundance of Clinical Data
The abundance of clinical data for actinic keratosis treatment is estimated to aid in the development of novel medications and therapies. The vast amount of clinical data available is being leveraged to understand and develop new and innovative options for effective treatment of actinic keratosis in different patients. Furthermore, availability of data regarding the treatment is also enabling dermatologists and surgeons to develop customized combination therapies for patients. These factors are estimated to provide a conducive platform for the development of novel treatment options and are expected to contribute significantly to the actinic keratosis market growth.
Non-profit organizations are conducting awareness programs to spread awareness among the general people regarding the methods of actinic keratosis treatment. The Skin Cancer Foundation has launched an awareness program named “Rays Awareness - Preventing Skin Cancer”, which explains the effect of UV radiation of sun and tanning beds, and their affects on the skin. Similarly, the British Association of Dermatologist also circulated a leaflet explaining the causes of actinic keratosis and their adverse effects. Such programs have increased the awareness level among people about the treatment in developed economies, which is consequently expected to increase the adoption for actinic keratosis treatment.
Dermatologists are increasingly adopting a combination of various methods for effectively treating actinic keratosis in patients. The combination of cryotherapy and fluorouracil cream exhibit a success rate of approximately 90% for the treatment of multiple actinic keratosis lesions. The combination of the two treatment offers a variety of benefits such as convenience of application and administration, lower irritability, and enhanced absorption of fluorouracil cream. Clinical trials have suggested enhanced outcome while using the combined therapy compared to the use of cryotherapy and fluorouracil cream individually. Combined fluorouracil and photodynamic therapy reduces actinic keratosis relative to the two treatment options used individually. Development of similar combination therapies is expected to increase the demand for different actinic keratosis treatment options.
Lack of Skilled Professionals
The actinic keratosis treatment by photodynamic therapy, cryotherapy or chemical peel requires skilled plastic surgeons. According to the WHO, it is expected to witness a shortage of 12.9 million healthcare workers by 2035 across the globe. The demand for plastic surgery has increased globally whereas the number of plastic surgeons has declined. Besides, the treatment-seeking rate of actinic keratosis is relatively low in developing countries owing to its low awareness among the population. Further, lack of awareness among end user is among the key factors which is restraining the growth of actinic keratosis treatment market across the globe.
Our-in depth analysis of the actinic keratosis treatment market includes the following segments:
By End User
- Hospitals & Oncology Centers
- Dermatology Clinics
- Ambulatory Surgical Centre
On the basis of regional analysis, the actinic keratosis treatment market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. North America market is anticipated to capture the largest market share in the actinic keratosis treatment market owing to developing predominance of actinic keratosis, better open mindfulness about event of actinic keratosis and related danger of squamous cell carcinoma. With the availability of advanced healthcare facilities, Asia Pacific region is expected to hold a significant market share by 2027.
The actinic keratosis treatment market is further classified on the basis of region as follows:
- North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
- Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
- Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC, Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
- Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis.
- Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis
Top Featured Companies Dominating the Market
- Leo Pharma
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Tolmar Pharmaceuticals
- DUSA Pharmaceuticals
- Valeant Pharmaceuticals International
- Aqua Pharmaceuticals
- Galderma SA
- Perrigo Company
- LEO Laboratories
- Other Prominent Players